User talk:Veselina Foteva

== Your submission at Articles for creation: FindMeCure - a patient search platform for clinical trials (February 10) ==  Your recent article submission to Articles for Creation has been reviewed! Unfortunately, it has not been accepted at this time. The reason left by SwisterTwister was:

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit when they have been resolved.


 * If you would like to continue working on the submission, go to Draft:FindMeCure - a patient search platform for clinical trials and click on the "Edit" tab at the top of the window.
 * If you need any assistance, you can ask for help at the or on the.
 * You can also use Wikipedia's real-time chat help from experienced editors.

SwisterTwister  talk  18:55, 10 February 2017 (UTC)

== Your submission at Articles for creation: FindMeCure - a patient search platform for clinical trials (August 24) ==  Your recent article submission to Articles for Creation has been reviewed! Unfortunately, it has not been accepted at this time. The reason left by Sulfurboy was:

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit when they have been resolved.


 * If you would like to continue working on the submission, go to Draft:FindMeCure - a patient search platform for clinical trials and click on the "Edit" tab at the top of the window.
 * If you need any assistance, you can ask for help at the or on the.
 * You can also use Wikipedia's real-time chat help from experienced editors.

Sulfurboy (talk) 23:42, 24 August 2017 (UTC)

Please do not add promotional material to Wikipedia. While objective prose about beliefs, organisations, people, products or services is acceptable, Wikipedia is not intended to be a vehicle for soapboxing, advertising or promotion. Thank you. SwisterTwister  talk  15:54, 25 August 2017 (UTC)